Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Sees Large Drop in Short Interest

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) was the recipient of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 286,000 shares, a decrease of 47.4% from the February 28th total of 543,400 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average daily volume of 846,100 shares, the short-interest ratio is presently 0.3 days.

Institutional Investors Weigh In On Bullfrog AI

A number of institutional investors and hedge funds have recently made changes to their positions in BFRG. Geode Capital Management LLC increased its holdings in Bullfrog AI by 31.0% during the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after buying an additional 11,140 shares during the last quarter. Two Sigma Securities LLC acquired a new position in shares of Bullfrog AI during the 4th quarter worth about $41,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Bullfrog AI in the 4th quarter valued at about $30,000. Institutional investors own 0.96% of the company’s stock.

Bullfrog AI Trading Down 6.1 %

Shares of Bullfrog AI stock traded down $0.11 during trading on Friday, reaching $1.70. The stock had a trading volume of 221,149 shares, compared to its average volume of 320,183. The company has a market capitalization of $16.01 million, a price-to-earnings ratio of -2.00 and a beta of 0.32. The stock has a fifty day moving average price of $2.37 and a two-hundred day moving average price of $2.37. Bullfrog AI has a 52 week low of $1.43 and a 52 week high of $4.84.

Bullfrog AI (NASDAQ:BFRG) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.18) earnings per share for the quarter.

Bullfrog AI Company Profile

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.